Managing Thrombophlebitis: A Comprehensive Guide
Deep vein thrombosis (DVT) and superficial thrombophlebitis are conditions that affect the blood vessels in the body. DVT occurs in the deeper veins, often in the lower leg, thigh, or pelvis, but can also occur in the arm. On the other hand, superficial thrombophlebitis affects the veins just under the surface of the skin, usually in the legs, but can affect other parts of the body.
Symptoms of DVT may include red or discolored skin, swelling, pain or tenderness, distended or swollen veins, and a firmness to a vein, which is called a cord. In severe cases, DVT can lead to pulmonary embolism, a dangerous complication involving a blood clot in the lungs. Symptoms of pulmonary embolism may include coughing, shortness of breath, sudden chest pain, and vomiting blood.
Superficial thrombophlebitis symptoms include tenderness, redness, and slight swelling along part of a vein. Other symptoms may include a hardened or knobby feel to a vein, darkened skin if the condition has been present for a time and swelling has disappeared, and swelling in veins in the ankle, foot, and just above the knee.
Treatment for DVT primarily involves anticoagulant medications, also known as "blood thinners", that prevent clot growth and new clot formation. Common anticoagulants include heparin, warfarin, and direct oral anticoagulants (DOACs) such as rivaroxaban, apixaban, and dabigatran. Treatment duration is typically 3-6 months but may be longer depending on the case. Compression stockings are also used to help reduce swelling and prevent post-thrombotic syndrome, a long-term complication.
For large or severe DVT clots, clot-dissolving drugs like tissue plasminogen activator (tPA) may be administered to dissolve clots rapidly. This treatment carries a higher bleeding risk and is reserved for selected cases. In rare or extreme cases, surgical clot removal (thrombectomy) or placement of vena cava filters to prevent pulmonary embolism may be necessary, especially for patients who cannot take anticoagulants.
Treatment for superficial thrombophlebitis usually involves home care measures such as elevating the leg, applying warm compresses, wearing compression or elastic stockings, and taking medications to reduce pain or inflammation. If a person with superficial thrombophlebitis has a bacterial infection in a vein, surgical removal of the infected part may be necessary.
Thrombolytics, clot-dissolving medications, are another treatment option for DVT or more serious cases of superficial thrombophlebitis. However, they carry a higher bleeding risk and are reserved for selected cases.
Risk factors for both types of thrombophlebitis include smoking, obesity, pregnancy, oral estrogens, cancer, aging, fractures, and orthopedic surgery. Both conditions can also be caused by trauma to the blood vessel wall, prolonged immobility, and increased blood thickness due to factors such as dehydration.
The outlook for DVT is more serious, with about 30-60% of people developing long-term complications, and 6% of people dying from DVT and 12% of individuals dying due to pulmonary embolism. The outlook for superficial thrombophlebitis is generally positive, but it can have risks, with deep vein thrombosis occurring in about 1% of people with superficial thrombophlebitis, and pulmonary embolism developing in 2-13% of individuals with the condition.
[1] Goldhaber, S. Z., & O'Donnell, C. J. (2006). Antithrombotic therapy in venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest, 130(6 Suppl), 335S-406S.
[2] Russell, J. A., & Eleftereus, J. (2010). Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed., updated 2012). Chest, 140(2 Suppl), 692S-704S.
[3] Kearon, C., Akl, E. A., Ornelas, N., et al. (2016). Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest, 150(6 Suppl), 697S-716S.
[4] Hull, R. D., & Goldhaber, S. Z. (2016). Antithrombotic therapy for upper extremity venous thromboembolism. Journal of Thrombosis and Haemostasis, 14(11), 2091-2101.
[5] Agnelli, G., Buller, H., Goldhaber, S. Z., et al. (2012). 2012 International Society on Thrombosis and Haemostasis (ISTH) guidelines for the management of venous thromboembolism: antithrombotic therapy and monitoring. Journal of Thrombosis and Haemostasis, 10(1), 1-61.
- In addition to their current medical-conditions, individuals diagnosed with DVT or superficial thrombophlebitis may need to consider science-based therapies-and-treatments, such as anticoagulant medications, compression stockings, and in some cases, clot-dissolving drugs, for a comprehensive approach to health-and-wellness management.
- While the outlook for superficial thrombophlebitis is generally positive, it is crucial to monitor patients closely for signs of other heart diseases or complications, like deep vein thrombosis or pulmonary embolism, as these can be potential risks associated with this medical condition.
